top of page
>
>
Strategic competitive intelligence assessments
Client Problems
- Understand the competitive landscape for several disease areas
- Gain insights from the design and success/failures of competitor clinical trials
- Evaluate strategic importance of PK and/or PD biomarkers
- Prioritize competitive threats based on a review of competitor MOA, published literature, and execution
What We Did
- We created a landscape of the current candidates in clinical trials for the disease areas across different MOAs
- Deep dive on the most relevant clinical trials and the competitor sponsors
- Gather insights from the clinical trial design of the competitors based on their success/failures and biomarker strategy.
Our Results And Insight
- Competitive landscape funnel – arranged by phase, MOA and patient characterization
- Assets under development by class and phase
- Competitor clinical trial and launch timelines
- Clinical trial deep dive
- Clinical trial endpoints and biomarker analysis
- Insights on clinical trial and biomarker strategy
See other case studies
Commercial Strategy case studies >
Central Nervous System case studies >
Service Areas Details
Commercial Strategy (Competitive Insights)
Therapeutic Areas Details
Central Nervous System (Alzheimer's, Parkinson's, ALS)
Featured Consultants
bottom of page